Cannabinoids: The Separation of Central from Peripheral Effects on a Structural Basis
The DOI matches its Crossref record.
Abstract
A brief history of the therapeutic uses and legal problems of cannabis as well as the component cannabinoids is given. This is followed by a discussion of drug development from Delta (1)-tetrahydrocannabinol and its synthetic analogues. The controversy of whether the pharmacological effects are of central or peripheral origin is included. Then, the potentials for the development of new drugs based on the cannabinoid structure for the treatment of pain, inflammation, and related conditions are outlined. It is concluded that the central activity of cannabinoids is confirmed and that the presence of a C-5 hydroxy group confers potent peripheral activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides the similarities with the opioid system, cannabinoids have also been shown to inhibit prostaglandin E-2 synthesis,8 reduce platelet aggregation,31 and have an anti-inflammatory effect twice as great as hydrocortisone and 20 times that of aspirin.12”
From Nabilone for the treatment of pain in fibromyalgia. (2008) · cites this paper as [12]
Citations
Cites
Still being checked.
Cited by
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
Nabilone for the treatment of pain in fibromyalgia.
Skrabek, R. Q., Galimova, L., Ethans, K., & Perry, D. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.002 · Cited by 384
Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads
Russo, E. B., & Marcu, J. (2017) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.03.004 · Cited by 368
Production and physiological actions of anandamide in the vasculature of the rat kidney.
Deutsch, D. G., Goligorsky, M. S., Schmid, P. C., Krebsbach, R. J., Schmid, H. H., Das, S. K., Dey, S. K., Arreaza, G., Thorup, C., Stefano, G., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119677 · Cited by 360
Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?
McPartland, J. M., & Russo, E. B. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n03_08 · Cited by 321
Cannabinoids in the management of difficult to treat pain
Russo, E. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1928 · Cited by 294
Cannabinoids in Clinical Practice
Williamson, E. M., & Evans, F. J. (2000) · Drugs · doi:10.2165/00003495-200060060-00005 · Cited by 283
Self-citationBaron, E. P. (2018) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 251
Costa, B., Colleoni, M., Conti, S., Parolaro, D., Franke, C., Trovato, A. E., & Giagnoni, G. (2004) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-004-0871-3 · Cited by 242
Borrelli, F., Pagano, E., Romano, B., Panzera, S., Maiello, F., Coppola, D., De Petrocellis, L., Buono, L., Orlando, P., & Izzo, A. A. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu205 · Cited by 225
Baron, E. P. (2015) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 206
Baron, E. P., Lucas, P., Eades, J., & Hogue, O. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0862-2 · Cited by 177
In vitro studies to evaluate the wound healing properties of Calendula officinalis extracts
Nicolaus, C., Junghanns, S., Hartmann, A., Murillo, R., Ganzera, M., & Merfort, I. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.12.006 · Cited by 171
Pain relief with oral cannabinoids in familial Mediterranean fever
Holdcroft, A., Smith, M., Jacklin, A., Hodgson, H., Smith, B., Newton, M., & Evans, F. (1997) · Anaesthesia · doi:10.1111/j.1365-2044.1997.139-az0132.x · Cited by 130
Self-citationDronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients
Schimrigk, S., Marziniak, M., Neubauer, C., Kugler, E. M., Werner, G., & Abramov-Sommariva, D. (2017) · European Neurology · doi:10.1159/000481089 · Cited by 136
Maayah, Z. H., Takahara, S., Ferdaoussi, M., & Dyck, J. R. B. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165771 · Cited by 114
Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects?
Wilkinson, J. D., Whalley, B. J., Baker, D., Pryce, G., Constanti, A., Gibbons, S., & Williamson, E. M. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022304 · Cited by 89
Maccarrone, M., Maldonado, R., Casas, M., Henze, T., & Centonze, D. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1292849 · Cited by 80
Cannabis for Inflammatory Bowel Disease
Naftali, T., Mechulam, R., Schleider, L. B., & Konikoff, F. M. (2014) · Digestive Diseases · doi:10.1159/000358155 · Cited by 87
Hryhorowicz, S., Kaczmarek-Ryś, M., Zielińska, A., Scott, R. J., Słomski, R., & Pławski, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.790803 · Cited by 87
McCarberg, B. H., & Barkin, R. L. (2007) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3180a5e581 · Cited by 86
Hemp for Headache: An In-Depth Historical and Scientific Review of Cannabis in Migraine Treatment
Russo, E. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n02_04 · Cited by 66
Jin, D., Henry, P., Shan, J. J., & Chen, J. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.699530 · Cited by 78
Towards cannabinoid drugs – revisited
Mechoulam, R., Hanus, L. O., & Fride, E. (1998) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70037-7 · Cited by 77
Nutraceuticals and Headache: The Biological Basis
Taylor, F. R. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01847.x · Cited by 76
Role of Cannabinoids in Pain Management
Russo, E. B., & Hohmann, A. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1560-2_18 · Cited by 70
The Pharmacological History of Cannabis
Russo, E. B. (2014) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199662685.003.0002 · Cited by 67
Shebaby, W. N., Saliba, J., Faour, W. H., Ismail, J., Hage, M. E., Daher, C. F., Taleb, R. I., Nehmeh, B., Dagher, C., Chrabieh, E. E., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113743 · Cited by 65
Russo, E. B., Cuttler, C., Cooper, Z. D., Stueber, A., Whiteley, V. L., & Sexton, M. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0058 · Cited by 63
Genaro, K., Fabris, D., Arantes, A. L. F., Zuardi, A. W., Crippa, J. A. S., & Prado, W. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00391 · Cited by 58
Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases
Mesa, X. M. R., Vergara, A. F. M., Bolaños, L. A. C., Guevara-Moriones, N., Piñeros, A. L. M., & González, S. P. S. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0183 · Cited by 49
Role of cannabis in inflammatory bowel diseases
Perisetti, A., Rimu, A. H., Khan, S. A., Bansal, P., & Goyal, H. (2020) · Annals of Gastroenterology · doi:10.20524/aog.2020.0452 · Cited by 45
Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues
Bilfinger, T. V., Salzet, M., Fimiani, C., Deutsch, D. G., Tramu, G., & Stefano, G. B. (1998) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00031-x · Cited by 45
Cannabinoids—Multifunctional Compounds, Applications and Challenges—Mini Review
Duczmal, D., Bazan‐Wozniak, A., Niedzielska, K., & Pietrzak, R. (2024) · Molecules · doi:10.3390/molecules29204923 · Cited by 43
The antinociceptive activity and mechanism of action of cannabigerol
Wen, Y., Wang, Z., Zhang, R., Zhu, Y., Lin, G., Li, R., & Zhang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114163 · Cited by 38
Ghovanloo, M., Estación, M., Higerd‐Rusli, G. P., Zhao, P., Dib‐Hajj, S. D., & Waxman, S. G. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15833 · Cited by 38
Health benefits, pharmacological properties, and metabolism of cannabinol: A comprehensive review
Khouchlaa, A., Khouri, S., Hajib, A., Zeouk, I., Amalich, S., Msairi, S., Menyiy, N. E., Raïs, C., Lahyaoui, M., Khalid, A., et al. (2024) · Industrial Crops and Products · doi:10.1016/j.indcrop.2024.118359 · Cited by 31
Medical marijuana and pain management
Temple, L. M. (2016) · Disease-a-Month · doi:10.1016/j.disamonth.2016.05.014 · Cited by 30
Biomedical benefits of cannabinoids?
Ashton, C. H. (1999) · Addiction Biology · doi:10.1080/13556219971623 · Cited by 29
Biological activity of Cannabis compounds: a modern approach to the therapy of multiple diseases
Helcman, M., & Šmejkal, K. (2021) · Phytochemistry Reviews · doi:10.1007/s11101-021-09777-x · Cited by 23
Anand, U., Oldfield, C., Pacchetti, B., Anand, P., & Sodergren, M. H. (2021) · Journal of Pain Research · doi:10.2147/jpr.s336773 · Cited by 23
Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer’s Disease
Rathod, S., & Agrawal, Y. O. (2023) · Current Drug Research Reviews · doi:10.2174/2589977515666230502104021 · Cited by 21
Meta‐analysis and review of cannabinoids extraction and purification techniques
Song, Y., Fürtös, A., Fuoco, D., Boumghar, Y., & Patience, G. S. (2023) · The Canadian Journal of Chemical Engineering · doi:10.1002/cjce.24786 · Cited by 21
Ghovanloo, M., Dib‐Hajj, S. D., Goodchild, S. J., Ruben, P. C., & Waxman, S. G. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1066455 · Cited by 22
Pharmacologie des dérivés cannabinoïdes : applications au traitement de la douleur ?
Beaulieu, P., & Rice, A. S. C. (2002) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(02)00663-9 · Cited by 20
Cannabigerol and Cannabicyclol Block SARS-CoV-2 Cell Fusion
Classen, N., Pitakbut, T., Schöfbänker, M., Kühn, J., Hrincius, E. R., Ludwig, S., Hensel, A., & Kayser, O. (2024) · Planta Medica · doi:10.1055/a-2320-8822 · Cited by 16
Cannabis sativa L. Constituents and Their Role in Neuroinflammation
Borgonetti, V., Governa, P., Montopoli, M., & Biagi, M. (2019) · Current Bioactive Compounds · doi:10.2174/1573407214666180703130525 · Cited by 16
Ghovanloo, M., Effraim, P. R., Tyagi, S., Zhao, P., Dib‐Hajj, S. D., & Waxman, S. G. (2024) · Communications Biology · doi:10.1038/s42003-024-05781-x · Cited by 16
Tan, K. B. C., Alexander, H. D., Linden, J., Murray, E. K., & Gibson, D. S. (2024) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2024.104924 · Cited by 11
Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
Gür, A., & Oktayoğlu, P. (2009) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s8040 · Cited by 10
Robson, P. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.2.164 · Cited by 8
McPartland, J. M. (2000) · Cited by 8
Cannabinoids‐Human Physiology and Agronomic Principles for Production
Williams, R. A., & Williams, D. W. (2019) · ASSA, CSSA and SSSA · doi:10.2134/industrialhemp.c5 · Cited by 7
Cannabis and Its Potential Protective Role Against Inflammatory Bowel Disease: A Scoping Review
Nso, N., Nyabera, A., Nassar, M., Alshamam, M. S., Sumbly, V., Vest, M., Patel, N. H., Ojong, G., & Rizzo, V. (2021) · Cureus · doi:10.7759/cureus.18841 · Cited by 7
Cannabis Roots: Therapeutic, Biotechnological and Environmental Aspects
Gagné, V., Boucher, N., & Desgagné-Penix, I. (2024) · Cannabis & Cannabinoid Research · doi:10.1089/can.2023.0168 · Cited by 6
The Medicalization of Cannabis
Crowther, S. M., Reynolds, L., & Em, T. (2010) · Queen Mary Research Online (Queen Mary University of London) · Cited by 6
Clarke, H. A., Roychoudhury, P., & Narouze, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_12 · Cited by 5
Rezende, B., Marques, K. L., de Carvalho, F. E. A., Gonçalves, V. M. D. S., de Oliveira, B. C. C. A., Nascimento, G. G., dos Santos, Y. B., Antunes, F., Barradas, P. C., Fontes-Dantas, F. L., et al. (2024) · Scientia Pharmaceutica · doi:10.3390/scipharm92030053 · Cited by 5
Drug interactions with Cannabis sativa: Mechanisms and clinical implication
Hasanpoor, A., Akaberi, M., Kesharwani, P., Sobhani, Z., & Sahebkar, A. (2023) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2023.10.004 · Cited by 4
Ożarowski, M., Mikołajczak, P. Ł., Bogacz, A., Bartkowiak-Wieczorek, J., Kujawski, R., Majchrzycki, M., Wielgus, K., Seremak‐Mrozikiewicz, A., & Czerny, B. (2014) · Journal of Medical Science · doi:10.20883/medical.e88 · Cited by 4
Non-NSAID over-the-counter (OTC) remedies for arthritis: good, bad or indifferent?
Whitehouse, M. W., & Butters, D. E. (1999) · Inflammopharmacology · doi:10.1007/s10787-999-0006-z · Cited by 4
Cannabis and Veterinary Medicine
Richter, G., & Hazzah, T. (2025) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2025.06.003 · Cited by 3
Overview of Medicinal Cannabis
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_4 · Cited by 3
Beaulieu, P., & Ware, M. A. (2004) · Drogues santé et société · doi:10.7202/008537ar · Cited by 2
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_141 · Cited by 1
Role of Cannabinoids in Pain Management
Russo, E. B., & Hohmann, A. G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1818-8_18 · Cited by 1
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-1 · Cited by 1
Le regard des sciences sociales
Moigne, P. L., & Velpry, L. (2006) · HAL · Cited by 1
Pharmacological actions and associated therapeutic levels of phytocannabinoids Addendum 2021
Arnold, J. C., Allsop, D., Lintzeris, N., & McGregor, I. S. (2016) · doi:10.57022/ovds2305 · Cited by 1
Jean, A. (2024) · eScholarship@McGill (McGill) · doi:10.82308/52639 · Cited by 1
Mathre, M. L. (2001) · The Drug and Alcohol Professional · doi:10.1108/17459265200100011
Arachidonate Derivatives as Endogenous Cannabinoid Substances
Piomelli, D. (1996) · Molecular biology intelligence unit · doi:10.1007/978-3-662-05807-7_6
McIver, V. C. (2020) · The Sydney eScholarship Repository (The University of Sydney)
Cannabigerol inhibits sodium conductance to reduce neuronal dorsal root ganglion excitability
Ghovanloo, M., Estación, M., Zhao, P., Dib‐Hajj, S. D., & Waxman, S. G. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2021.11.2240
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-2
Fink, J. A. M. (2016) · Unipub UB Graz (Universität Graz)
Validación de una técnica de detección de THC y CBD en suero sanguíneo de perros mediante HPLC-UV
Sosa Mayuncaldi, S. E. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Quantitative Analysis of Tetrahydrocannabinol For Forensic Applications In Seized Drugs
Gannaway, J. (2017) · Pittsburg State University Digital Commons (Pittsburg State University)
Caractérisation thérapeutique d'extraits de racines de Cannabis sativa L.
Gagné, V. (2024) · e-Theses (Université du Québec à Trois-Rivières)
The Endocannabinoid System and Medicinal Cannabis
O’Brien, K., & Bosak, C. (2025) · Springer eBooks · doi:10.1007/978-3-032-01737-6_2
Rusznák, K. (2024) · Pesci Egyetemi Archivum (University of Pécs)
Überblick über medizinisches Cannabis
O’Brien, K., & Blair, P. (2026) · Springer eBooks · doi:10.1007/978-3-032-14521-5_4
Metadata
- Authors
- Evans, F.
- Affiliations
- University of London (GB)
- Corresponding author
- Evans, Fred
- Venue
- Planta Medica
- Publisher
- Georg Thieme Verlag KG
- Published
- 1991-10
- Volume
- 57
- Issue
- S 1
- Pages
- S60-S67
- ISSN
- 0032-0943 (ISSN-L)
- 1439-0221
- OpenAlex
- W2050366726
- Cited by
- 76
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 8 · 2023: 5 · 2022: 3 · 2021: 10 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 5 · 2012: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Planta Medica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Keywords
- cannabinoids, delta-1-tetrahydrocannabinol, cannabis, central nervous system effects, peripheral effects, pain, inflammation, synthetic cannabinoids
- MeSH terms
- Animals, Cannabinoids, Central Nervous System, Humans, Inflammation, Pain, Peripheral Nerves, Structure-Activity Relationship, Dronabinol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.